Mammal Cells May Already Know How To Regenerate. Scientists Just Discovered How.

Two Proteins, Applied in the Right Order, Helped Mice Regrow Amputated Finger Bones

Salamanders can regrow entire limbs and Starfish can regenerate lost arms. But mammals? They’ve (We’ve) long been considered out of luck when it comes to regrowing lost body parts. Now, however, a team of researchers working with mice coaxed the regrowth of amputated finger bones using a carefully timed, sequential treatment with two growth-signaling proteins. The result challenges the longstanding assumption that mammalian wounds are destined to heal with scar tissue instead of new structures.

Published in Nature Communications, the study found that treating amputated mouse digits first with a protein called FGF2 and then with a protein called BMP2 triggered the regrowth of bone, joint tissue, tendons, and ligaments. In some cases, the combined response covered multiple skeletal structures removed by the amputation. The regrowth wasn’t perfect. But the fact that it happened at all, at a wound site that would normally just scar over, marks a real shift in how scientists think about regeneration in mammals.

How Two Proteins Triggered Bone Regrowth in Mice

To grasp why this matters, it helps to know a bit about how regeneration works in animals that are good at it. Salamanders regrow limbs by forming a cluster of unspecialized cells at a wound site. That cluster then reorganizes into the missing body part. Mammals can do a limited version of this at the very tips of their fingers and toes. Children who lose fingertips in accidents sometimes regrow them. But amputation at slightly deeper levels results in scarring, not regrowth.

Led by senior researcher Ken Muneoka and colleagues at Texas A&M University, Tulane University, Arizona State University, Stanford University, and the Ludwig Boltzmann Institute for Traumatology in Vienna, the team tested what would happen if they amputated mouse digits at a level that does not normally regenerate, then applied growth-signaling proteins to the wound. FGF2, delivered first, stimulated wound cells to form a regeneration-ready cluster, kick-starting the process. BMP2, a bone-building signal, was then applied to instruct those cells to become bone and other tissues.

Order mattered. FGF2 first, then BMP2. That one-two sequence drove the regrowth.

Cell-tracking studies revealed that wound cells may have been reprogrammed, diverted from their default scarring path toward rebuilding lost bone and joint. Evidence from the study points to organized rebuilding that appeared to mirror how bones originally form during embryonic development.

Two Separate Regeneration Responses at the Same Wound Site

Perhaps most unexpectedly, the researchers found the treatment triggered two distinct regeneration responses at the same time. One followed the expected pathway: wound cells formed a cluster that then became the missing bone segment. The second was entirely different. It regenerated a joint-like structure with features of a synovial joint, the lubricated, hinge-type joint found between finger bones, along with tendon, ligament, and a small bone similar to a kneecap.

Together, the two responses could account for multiple skeletal components removed by the amputation. The paper notes the regeneration was “imperfect,” but the range of tissue types that grew back from a wound that would otherwise have simply scarred over is notable.

The Cells Were There All Along

One of the big questions in regeneration research has been whether mammals lack the right cells for regeneration, or whether they simply lack the right signals. This study makes a strong case for the second option. As the researchers write, the induced regeneration response “demonstrates the availability of regeneration competent cells at a non-regenerating wound, and that FGF and BMP signaling is sufficient to trigger a regenerative outcome at wounds that heal by fibrosis.”

Put plainly, the raw materials for regeneration are already sitting at the wound. The cells just need to be told what to do.

Scarring is the default mammalian wound-healing response. Cut yourself, break a bone badly, or lose a body part, and the body patches things up with fibrous tissue rather than rebuilding what was lost. Scientists have often described this as an evolutionary tradeoff: fast wound closure at the expense of true regeneration. The sequential FGF2-then-BMP2 approach appears to override that default, steering the wound response from scarring toward regrowth.

What Mouse Finger Bone Regeneration Could Mean

Translating findings from mice to humans is always a leap, and this study is a long way from being used in a clinic. Whether this approach would work in larger animals or humans remains unknown. FGF2 and BMP2 are not exotic molecules; both are well-studied growth factors already used in various medical settings. But no one should expect to regrow a lost finger anytime soon.

Still, the core finding, that mammalian wound cells may retain the ability to regenerate when given the right molecular instructions in the right order, reopens a question many had considered settled. Regenerative failure in mammals now looks less like a hard biological limit and more like a problem of missing signals. Getting those signals right in humans is where the real work begins.

---